• Explore /
  • Poster
  • / Sustainability and clinical outcomes of routine screening for pathogenic DPYD gene variants prior to fluoropyrimidine (FP) chemotherapy for gastrointestinal (GI) cancer.

Sustainability and clinical outcomes of routine screening for pathogenic DPYD gene variants prior to fluoropyrimidine (FP) chemotherapy for gastrointestinal (GI) cancer.

Abstract Poster

Authors

null

Gabriel A. Brooks

Norris Cotton Cancer Center, Lebanon, NH

Gabriel A. Brooks, Mohammad Waleed, Elizabeth Boutin McGrath, Kara Beloin, Sarah K. Walsh, Philip R. Benoit, Wahab A. Khan, Gregory J. Tsongalis, Manik A. Amin, Jason Edward Faris, Gregory H. Ripple, Kathryn Cunningham Hourdequin

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Patient Experience; Quality, Safety, and Implementation Science; Technology and Innovation in Quality of Care

Track

Technology and Innovation in Quality of Care,Patient Experience,Quality, Safety, and Implementation Science,Cost, Value, and Policy,Health Care Access, Equity, and Disparities

Sub Track

Patient Safety

Citation

J Clin Oncol 39, 2021 (suppl 28; abstr 216)

DOI

10.1200/JCO.2020.39.28_suppl.216

Abstract #

216

Poster Bd #

B20

Abstract Disclosures

Similar Posters

First Author: Côme De Metz

First Author: Jai Narendra Patel

First Author: Gabriel Brooks

First Author: Michele Boisdron-Celle